2021 CMSC Annual Meeting

Tag: (2)Day Care Unit

Poster-Disease-modifying Therapy

Natalizumab: Management and Safety during the COVID-19 Pandemic

Background: MS patients treated with monoclonal antibodies have an increased risk of infections. Natalizumab (NTZ) is a monoclonal antibody...

Read More